About this trial
Treatment for acute traumatic thoracolumbar burst fractures differs significantly across the world in patients without neurological impairments and without damage to the posterior column of the spine. This randomized controlled, non-inferiority clinical trial's goal is to evaluate the effectiveness of surgery versus initial non-surgical treatment for patients with traumatic thoracolumbar spine burst fractures who don't have any neurological symptoms.
The study's precise objectives are to:
1. evaluate the clinical outcome (Oswestry Disability Index) 2. evaluate the radiography result (restoration and maintenance of spinal alignment) 3. determine the prevalence of complications
at least 24 months of follow-up of neurologically unaffected patients with acute traumatic burst fractures. Both groups will get the same therapy using standardized methods: The surgical group's entire patient population will get combined anterior-posterior (360°) spinal fusion therapy. Three-point hyperextension orthoses will be used to treat all patients in the non-surgical group for six weeks following the injury.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age 18 - 70 years at inclusion
Acute traumatic burst fracture of the thoracolumbar spine (10th thoracic to 3rd lumbar vertebral body)
Informed consent for study participation
Disqualifiers
Injury of the posterior tension band/posterior column of the thoracolumbar spine
Any neurological deficit (American Spinal Injury Association Impairment Scale [AISA] Grade A-D)
Pathological vertebral body fractures (diagnosed by MRI and CT scan), which, in the opinion of the research/investigative team, would compromise (or interfere with) patients' ability to participate in the study
Concomitant spinal fractures at any other level of the spine outside the T10-L3 level, which, in the opinion of the research/investigative team, would compromise (or interfere with) patients' ability to participate in the study
Trial design
Parallel
Treatments tested in this trial
Surgical stabilization
Procedure/SurgeryAnterior-posterior stabilization (360°) with pedicle screws and an expandable cage
Treatment groups
Trial outcomes
Primary outcomes
The clinical outcome as assessed by the Oswestry Disability Index (ODI) 104 weeks post-surgery or non-surgical treatment initiation
ODI is a patient-reported outcome measure for spinal disorders. It consists of 10 questions related to back specific disabilities such as pain, personal care, walking and sitting ability, lifting capacity and social life.
Secondary outcomes
Radiological outcome: Mono- (A3-fractures)/Bisegmental (A4-fractures) kyphosis angle
Bi-/segmental kyphosis (Gardner/Cobb angle) assessed by long-standing x-rays of the entire spine
Radiological outcome: Spinal fusion and fracture consolidation
Spinal fusion in the surgical group and fracture consolidation in the non-surgical group assessed by CT-scan
Radiological outcome: Segment mobility
Segment mobility assessed by functional lateral views at 52 weeks and compared between treatment groups
Radiological outcome: Degeneration of the intervertebral disc over time
Degeneration of the intervertebral disc (Pfirrmann grade)
Other outcomes
Radiological outcome: Fracture comminution
Fracture comminution of the vertebral body
Radiological outcome: Classification of traumatic disc injury
Sanders Classification
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Insel Gruppe AG, University Hospital Bern
Lead sponsor
Cantonal Hospital of St. Gallen
Collaborator